Evolva Holding SA has been collaborating with International Flavors & Fragrances, Inc. (IFF) since early 2011 to develop a bionsynthetic route for sustainable production of flavor ingredient. With the project progressing on schedule, the two companies decided to add another ingredient. Under the four-year agreement, IFF will give Evolva an upfront payment, monthly research fees and royalties; Evolva will focus on pathway discovery and yield stages of the program, up through the scale-up and manufacturing phases.
"Our first project with IFF is progressing well and we are excited about extending the collaboration," says Evolva CEO Neil Goldsmith. "It is clear our biosynthesis platform is delivering radically new products and processes. These have the potential to open up markets that were previously constrained by cost, production or supply chain factors."